BNP in hormone-guided treatment of heart failure
- 1 May 2002
- journal article
- clinical trial
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 13 (4) , 151-155
- https://doi.org/10.1016/s1043-2760(01)00554-9
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Role of the renin-angiotensin system in the development of hemodynamic and clinical tolerance to long-term prazosin therapy in patients with severe chronic heart failurePublished by Elsevier ,2010
- Evolving trends in the epidemiologic factors of heart failure: Rationale for preventive strategies and comprehensive disease managementAmerican Heart Journal, 1997
- The heart failure epidemic: magnitude of the problem and potential mitigating approachesCurrent Opinion in Cardiology, 1996
- A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart FailureNew England Journal of Medicine, 1991
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- Vasodilator and inotropic therapy for severe chronic heart failure: Passion and skepticismJournal of the American College of Cardiology, 1983
- Hemodynamic Characterization of Tolerance to Long-Term Hydralazine Therapy in Severe Chronic Heart FailureNew England Journal of Medicine, 1982
- Long-term therapy of heart failure with prazosin: A randomized double blind trialPublished by Elsevier ,1980
- Vasodilator Therapy of Cardiac FailureNew England Journal of Medicine, 1977
- Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation.Circulation Research, 1976